Human telomerase reverse transcriptase-immortalized MRC-5 and HCA2 human fibroblasts are fully permissive for human cytomegalovirus

被引:66
作者
McSharry, BP
Jones, CJ
Skinner, JW
Kipling, D
Wilkinson, GWG
机构
[1] Univ Wales Coll Med, Dept Med, Cardiff CF14 4XX, S Glam, Wales
[2] Univ Wales Coll Med, Dept Pathol, Cardiff CF14 4XX, S Glam, Wales
关键词
D O I
10.1099/0022-1317-82-4-855
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
MRC-5 cells are a well-characterized human diploid fibroblast cell line approved for vaccine production and favoured for the routine propagation of human cytomegalovirus (HCMV). Ectopic expression of telomerase in fibroblasts is capable of overcoming replicative senescence induced by telomere shortening. Following delivery of the hTERT gene to MRC-5 cells using a retrovirus vector three clones were generated that (i) expressed functional telomerase activity, (ii) exhibited telomere extension and (iii) were sustained for > 100 population doublings, Immortalized MRC-5-hTERT and also HCA2-hTERT human fibroblasts were both fully permissive for HCMV as determined by plaque assay, studies of virus growth kinetics and measurement of virus yields. Furthermore, telomerase-immortalized HCA2 cells proved capable of Supporting the stable maintenance of an EBV-based episomal vector with efficient transgene expression when driven by the HCMV immediate early promoter. An indicator cell line suitable for the efficient detection of HCMV infection was also generated using an episome containing a reporter gene (lacZ) under the control of the HCMV beta -2.7 early promoter. Telomerase immortalization of human fibroblasts will thus facilitate the growth and detection of HCMV and also the generation of helper cell lines for the propagation of HCMV deletion mutants. Immortalization of fibroblasts by telomerase does not affect cell morphology or growth characteristics. The MRC-5-hTERT clones may therefore be suitable for additional applications in virology, cell biology, vaccine production and biotechnology.
引用
收藏
页码:855 / 863
页数:9
相关论文
共 41 条
[1]   HIV-1 INDICATOR CELL-LINES [J].
AKRIGG, A ;
WILKINSON, GWG ;
ANGLISS, S ;
GREENAWAY, PJ .
AIDS, 1991, 5 (02) :153-158
[2]   Human CD8+ T cell responses to EBV EBNA1:: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing [J].
Blake, N ;
Lee, S ;
Redchenko, I ;
Thomas, W ;
Steven, N ;
Leese, A ;
Steigerwald-Mullen, P ;
Kurilla, MG ;
Frappier, L ;
Rickinson, A .
IMMUNITY, 1997, 7 (06) :791-802
[3]   Extension of life-span by introduction of telomerase into normal human cells [J].
Bodnar, AG ;
Ouellette, M ;
Frolkis, M ;
Holt, SE ;
Chiu, CP ;
Morin, GB ;
Harley, CB ;
Shay, JW ;
Lichtsteiner, S ;
Wright, WE .
SCIENCE, 1998, 279 (5349) :349-352
[4]   COMPARISON OF MRC-5 AND U-373MG ASTROCYTOMA-CELLS FOR DETECTION OF CYTOMEGALOVIRUS IN SHELL VIAL CENTRIFUGATION CULTURES [J].
BOECKH, M ;
GLEAVES, CA ;
BINDRA, R ;
MEYERS, JD .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (07) :569-572
[5]   Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains [J].
Cha, TA ;
Tom, E ;
Kemble, GW ;
Duke, GM ;
Mocarski, ES ;
Spaete, RR .
JOURNAL OF VIROLOGY, 1996, 70 (01) :78-83
[7]   SAFE AND EFFICIENT GENERATION OF RECOMBINANT RETROVIRUSES WITH AMPHOTROPIC AND ECOTROPIC HOST RANGES [J].
DANOS, O ;
MULLIGAN, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (17) :6460-6464
[8]  
Faragher RGA, 1998, BIOESSAYS, V20, P985, DOI 10.1002/(SICI)1521-1878(199812)20:12<985::AID-BIES4>3.3.CO
[9]  
2-1
[10]   GROWTH-KINETICS OF HUMAN CYTOMEGALOVIRUS ARE ALTERED IN MONOCYTE-DERIVED MACROPHAGES [J].
FISH, KN ;
DEPTO, AS ;
MOSES, AV ;
BRITT, W ;
NELSON, JA .
JOURNAL OF VIROLOGY, 1995, 69 (06) :3737-3743